Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Landos Biopharma, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 20 | 8 | −12 |
| Shares | 15.5M | 1.49M | −14.0M (−90.4%) |
| Value | $4.63M | $6.27M | +$1.64M (+35.3%) |
New holders (0)
Institutions that held Landos Biopharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (12)
Institutions that held Landos Biopharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Macquarie Group Ltd | 147,182 | $44.0K |
| Geode Capital Management, LLC | 91,538 | $27.3K |
| Citadel Advisors LLC | 86,093 | $25.7K |
| Renaissance Technologies LLC | 79,201 | $24.0K |
| Warberg Asset Management LLC | 73,504 | $21.9K |
| Bridgeway Capital Management, LLC | 39,000 | $11.6K |
| State Street Corp | 25,200 | $7.51K |
| Vanguard Group Inc | 23,995 | $7.15K |
| Susquehanna International Group, LLP | 14,976 | $4.46K |
| Northern Trust Corp | 12,219 | $3.64K |
| Green Square Capital Advisors LLC | 10,000 | $2.98K |
| Bank of America Corp | 26 | $8 |